Stock Price
1.49
Daily Change
-0.01 -0.34%
Monthly
-7.19%
Yearly
30.26%
Q2 Forecast
1.38

Autolus Therapeutics Ltd reported $25.33M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AstraZeneca USD 3.27B 471M Dec/2025
Autolus Therapeutics Ltd USD 25.33M 3.31M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Novartis USD 3.54B 3M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Silence Therapeutics USD 12K 52K Dec/2025